ProfileGDS4718 / 238741_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 61% 65% 53% 64% 59% 56% 60% 60% 63% 56% 63% 58% 58% 54% 63% 53% 57% 57% 55% 60% 57% 60% 58% 61% 56% 53% 58% 53% 56% 58% 59% 55% 64% 61% 57% 57% 56% 59% 59% 59% 58% 62% 54% 54% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.2004361
GSM549102patient 115, normal, homogenized [OPG study]6.5032165
GSM549104patient 119, normal, homogenized [OPG study]5.6927153
GSM549108patient 138, normal, homogenized [OPG study]6.3771364
GSM549119patient 077, normal, homogenized [OPG study]6.067859
GSM549133patient 032, cancer, homogenized [OPG study]5.8536156
GSM549139patient 042, cancer, homogenized [OPG study]6.1325460
GSM549099patient 107, normal, homogenized [OPG study]6.1000360
GSM549109patient 139, normal, homogenized [OPG study]6.3408263
GSM549110patient 046, normal, homogenized [OPG study]5.8957556
GSM549114patient 063, normal, homogenized [OPG study]6.2836663
GSM549122patient 082, normal, homogenized [OPG study]6.0239958
GSM549134patient 033, cancer, homogenized [OPG study]5.9603258
GSM549136patient 036, cancer, homogenized [OPG study]5.7085654
GSM549140patient 044, cancer, homogenized [OPG study]6.3241263
GSM549111patient 047, normal, homogenized [OPG study]5.6781753
GSM549113patient 057, normal, homogenized [OPG study]5.8983857
GSM549132patient 031, cancer, homogenized [OPG study]5.948857
GSM549137patient 038, cancer, homogenized [OPG study]5.8318555
GSM549142patient 047, cancer, homogenized [OPG study]6.2014260
GSM549100patient 110, normal, homogenized [OPG study]5.9400957
GSM549107patient 135, normal, homogenized [OPG study]6.0991960
GSM549115patient 068, normal, homogenized [OPG study]5.980758
GSM549116patient 072, normal, homogenized [OPG study]6.2238861
GSM549120patient 078, normal, homogenized [OPG study]5.8847956
GSM549131patient 030, cancer, homogenized [OPG study]5.6340653
GSM549118patient 074, normal, homogenized [OPG study]6.0028358
GSM549129patient 027, cancer, homogenized [OPG study]5.6951953
GSM549123patient 088, normal, homogenized [OPG study]5.889456
GSM549124patient 006, cancer, homogenized [OPG study]6.0409858
GSM549126patient 015, cancer, homogenized [OPG study]6.0257559
GSM549128patient 025, cancer, homogenized [OPG study]5.8092355
GSM549103patient 117, normal, homogenized [OPG study]6.376664
GSM549117patient 073, normal, homogenized [OPG study]6.1561861
GSM549138patient 041, cancer, homogenized [OPG study]5.9247857
GSM549141patient 045, cancer, homogenized [OPG study]5.8927857
GSM549130patient 028, cancer, homogenized [OPG study]5.8859556
GSM549101patient 111, normal, homogenized [OPG study]6.1062659
GSM549105patient 128, normal, homogenized [OPG study]6.0923959
GSM549106patient 134, normal, homogenized [OPG study]6.0103159
GSM549112patient 048, normal, homogenized [OPG study]6.000658
GSM549125patient 011, cancer, homogenized [OPG study]6.2345862
GSM549127patient 024, cancer, homogenized [OPG study]5.7882454
GSM549135patient 035, cancer, homogenized [OPG study]5.6919654